AbstractBackgroundStandard approaches to estimation of Markov models with data from randomized controlled trials tend either to make a judgment about which transition(s) treatments act on, or they assume that treatment has a separate effect on every transition. An alternative is to fit a series of models that assume that treatment acts on specific transitions. Investigators can then choose among alternative models using goodness-of-fit statistics. However, structural uncertainty about any chosen parameterization will remain and this may have implications for the resulting decision and the need for further research.MethodsWe describe a Bayesian approach to model estimation, and model selection. Structural uncertainty about which parameteriza...
Random effects contain crucial information to understand the variability of the processes under stud...
Bayesian Model Averaging (BMA) has previously been proposed as a solution to the variable selection ...
International audienceIn drug development, pharmacometric approaches consist in identifying via a mo...
AbstractBackgroundStandard approaches to estimation of Markov models with data from randomized contr...
Decision analytic models used for health technology assess-ment are subject to uncertainties. These ...
Health economic decision models are subject to various forms of uncertainty, including uncertainty a...
We consider the problem of assessing new and existing technologies for their cost-effectiveness in t...
We consider the problem of assessing new and existing technologies for their cost-effectiveness in t...
Standard statistical practice ignores model uncertainty. Data analysts typically select a model from...
This study considered the problem of predicting survival, based on three alternative models: a singl...
We consider the problem of assessing new and existing technologies for their cost-effectiveness in ...
We consider the problem of assessing new and existing technologies for their cost-effectiveness in t...
Health economic decision models are subject to considerable uncertainty, much of which arises from c...
Standard statistical practice ignores model uncertainty. Data analysts typically select a model from...
There is a need for cost-effective tools to identify a small fraction of the population with a high ...
Random effects contain crucial information to understand the variability of the processes under stud...
Bayesian Model Averaging (BMA) has previously been proposed as a solution to the variable selection ...
International audienceIn drug development, pharmacometric approaches consist in identifying via a mo...
AbstractBackgroundStandard approaches to estimation of Markov models with data from randomized contr...
Decision analytic models used for health technology assess-ment are subject to uncertainties. These ...
Health economic decision models are subject to various forms of uncertainty, including uncertainty a...
We consider the problem of assessing new and existing technologies for their cost-effectiveness in t...
We consider the problem of assessing new and existing technologies for their cost-effectiveness in t...
Standard statistical practice ignores model uncertainty. Data analysts typically select a model from...
This study considered the problem of predicting survival, based on three alternative models: a singl...
We consider the problem of assessing new and existing technologies for their cost-effectiveness in ...
We consider the problem of assessing new and existing technologies for their cost-effectiveness in t...
Health economic decision models are subject to considerable uncertainty, much of which arises from c...
Standard statistical practice ignores model uncertainty. Data analysts typically select a model from...
There is a need for cost-effective tools to identify a small fraction of the population with a high ...
Random effects contain crucial information to understand the variability of the processes under stud...
Bayesian Model Averaging (BMA) has previously been proposed as a solution to the variable selection ...
International audienceIn drug development, pharmacometric approaches consist in identifying via a mo...